CN100427113C - Ruankang good for breast - Google Patents
Ruankang good for breast Download PDFInfo
- Publication number
- CN100427113C CN100427113C CNB2004100311191A CN200410031119A CN100427113C CN 100427113 C CN100427113 C CN 100427113C CN B2004100311191 A CNB2004100311191 A CN B2004100311191A CN 200410031119 A CN200410031119 A CN 200410031119A CN 100427113 C CN100427113 C CN 100427113C
- Authority
- CN
- China
- Prior art keywords
- breast
- treating
- medicine
- blood
- ruankang
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000481 breast Anatomy 0.000 title abstract description 32
- 239000003814 drug Substances 0.000 claims abstract description 18
- 206010006187 Breast cancer Diseases 0.000 claims abstract description 13
- 208000026310 Breast neoplasm Diseases 0.000 claims abstract description 13
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 5
- 239000004863 Frankincense Substances 0.000 claims abstract description 5
- 208000004396 mastitis Diseases 0.000 claims abstract description 4
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 3
- 239000002775 capsule Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 6
- 201000008275 breast carcinoma Diseases 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 4
- 241000972155 Moschus Species 0.000 claims description 4
- 241001057584 Myrrha Species 0.000 claims description 4
- 210000005075 mammary gland Anatomy 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000008961 swelling Effects 0.000 abstract description 6
- 206010020718 hyperplasia Diseases 0.000 abstract description 4
- 201000008827 tuberculosis Diseases 0.000 abstract description 4
- 230000017423 tissue regeneration Effects 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 241000202807 Glycyrrhiza Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a breast treating medicine for radically treating mastitis, tuberculosis of breast, hyperplasia of breast,breast tumor and breast cancer. The formula of the medicine comprises the main components: dahurian angelica, olibanum, myrrh, musk, dandelion, angelica, weeping forsythia capsule, fried glycyrrhiza, honeysuckle flower and the like. The breast treating medicine has efficiency of promoting blood circulation to remove blood stasis, clearing heat, detoxicating, eliminating swelling and relieving pain, and particularly has high treating effect and short treating period in treating diseases including breast cancer, and the like. The breast treating medicine has the functions of promoting blood flow but not damaging the blood, regulating qi but not exhausting qi, generating new blood, promoting tissue regeneration, enhancing immunological functions and increasing recovering functions. The breast treating medicine inhibits and kills cancer cells to achieve the effects of resisting and curing disease. Generally speaking, people can recover after taking the medicine for 7 to 28 days, and the effective rate can reach 98%.
Description
Technical field:
The invention belongs to the Chinese medicine collocation method, the field of Chinese herbal medicine technology of the definite treatment cystic hyperplasia of breast of saying so.
Background technology:
Cystic hyperplasia of breast is that the women enters later commonly encountered diseases of middle age, high morbidity.Show according to data: among the women more than three teens, suffers from cystic hyperplasia of breast in various degree more than 54%, common have mastitis, tuberculosis of breast, cyclomastopathy, breast tumor, breast carcinoma, and show a rising trend the serious physical and mental health that is threatening numerous women year by year.Mastopathy, how because of due to qi depression to blood stasis causes that QI and blood expectorant food stagnancy knot gathers, people's life is jeopardized in ill back as can not in time obtain medical treatment or malpractice causes that sb.'s illness took a turn for the worse.The treatment breast cancer disease adopts the Therapeutic Method of antibiotic, chemotherapy, excision more at present, and these methods are bigger to the misery that the patient causes, and treatment cycle is long, cure rate is low, relapse rate height, medical expense height, what have also can have side effects, and does not reach the effect of radical cure.
Summary of the invention:
The present invention be directed to above prior art not enough and provide a kind of no pain, effectively kill breast cancer cell, cure rate height, the curative effect phase is short, expense is low, and can activating blood circulation to dissipate blood stasis, Chinese medicine preparation---the Ruankang good for breast of heat-clearing and toxic substances removing, reducing swelling and alleviating pain, conditioning energy and blood of human body.
Ruankang good for breast medicine of the present invention is achieved in that its Chinese medicinal ingredients and weight proportion are as follows
The Ruankang good for breast pharmaceutical compositions is as follows: medicines such as the Radix Angelicae Dahuricae, Olibanum, Myrrha, Moschus, Herba Taraxaci, Radix Angelicae Sinensis body, Fructus Forsythiae, Radix Glycyrrhizae Preparata, Flos Lonicerae.
Ruankang good for breast drug ratio weight is as follows:
The Radix Angelicae Dahuricae 3～10g, Olibanum 3～10g, Myrrha 6～15g, Moschus 0.2～3g, Herba Taraxaci 10～18g, Radix Angelicae Sinensis body 3～10g, Fructus Forsythiae 6～15g, Radix Glycyrrhizae Preparata 3～10g, Flos Lonicerae 20～35g
The Ruankang good for breast medicine property of medicine of the present invention pharmacological action is analyzed as follows:
The Radix Angelicae Dahuricae: be the medicine commonly used of diseases such as skin sore, the evacuation of pus effect of invigorating blood circulation.
Olibanum: blood circulation promoting regulates qi, pain relieving granulation promoting, can control effects such as carbuncle, all skin ulcers of toxic swelling, diffusing congestion pain relieving.
Myrrha: the pain of eliminating stasis to stop pain, particularly qi depression to blood stasis has the effect of the poly-lump of broken congestion eliminate indigestion.
Moschus: the key medicine of the fragrance of having one's ideas straightened out, be open to the custom have one's ideas straightened out, promoting blood circulation and stopping pain, the meridian dredging effect.
Herba Taraxaci: heat-clearing and toxic substances removing, dissipation carbuncle, eliminate hard lump and tuberculosis, especially the carbuncle furunculosis of breast.
The Radix Angelicae Sinensis body: hemopoietic, reinforcing the heart blood, hold up effect beneficial deficient, repercussive tissue regeneration promoting flesh.
Fructus Forsythiae: heat-clearing and toxic substances removing, repercussive swell, and can control the obstructed skin sore that produces of the QI and blood that causes because of pyretic toxicity.The effect of the heat radiation of clearing away heart-fire is arranged.
Radix Glycyrrhizae Preparata: warming middle-JIAO, coordinating the actions of various ingredients in a prescription, separate hundred poison, invigorating the spleen and replenishing QI.
Flos Lonicerae: but heat-clearing and toxic substances removing, carbuncle sore tumefacting virus there is better curative effect, can not subside a swelling when suppurating, but expelling pus and toxin by strengthening QI after the suppuration impels recovery from illness early.
In a word, Ruankang good for breast of the present invention adopts removing blood stasis, eliminating stagnation, softening hard piece, it is pleasant to regulate the flow of vital energy, accomplish the not bad blood of removing blood stasis, regulate the flow of vital energy do not loose gas, to internal organs to eliminate bad blood, to loose and remove scleroma, give birth to the long new flesh of painstaking effort, the subsidence of swelling powder stasis of blood, raise immunity, improve the recovery from illness function.Make the mutual compatibility of the property of medicine, the coordinating effect that performance is maximum.Cancerous cell is suppressed and kills and wounds, reach disease-resistant, diseases prevention, remove the curative effect of disease.
The present invention is on the basis of secret prescription handed down in the family from generation to generation and the technological means of science compatibility, to diseases such as mastitis, mammary gland tumor, tuberculosis of breast, cyclomastopathy, breast carcinoma, but activating blood circulation to dissipate blood stasis, heat clearing away toxin expelling, reducing swelling and alleviating pain generally can be recoveries from illness in 7-28 days, and effective percentage can reach 98%.
The processing technology of Ruankang good for breast of the present invention:
With said herbal medicine thing of the present invention, through screening, cleaning, oven dry, grind superfine powder by weight ratio, mix homogeneously is made powder or encapsulated taking.
Ruankang good for breast medicine of the present invention: gas fragrance, sweet, the little hardship of flavor.
Usage and consumption: powder once a day, consumption is 7g, takes after the supper.Capsule one day twice, early after ante cibum, the supper one hour, 6 of ampoules (about 3g).
Be not taken by pregnant women.
Case:
Mengjin, Henan Cui's wife extracts left operation on breast because of suffering from breast cancer, and right breast shifts after 1 year.Obey Ruankang good for breast 28 days and heal no abnormal situation appearance in 8 years.
XX is opened in Luoyang, Henan, the male, and the caking enlargement appears in shirtfront breast portion.Clothes Ruankang good for breast ten days and healing normally was as good as in 7 years so far.
Luoyang, Henan Liu XX, the women, mammary gland pain, hospital diagnosis are breast carcinoma, require operation.Liu takes Ruankang good for breast, and 26 days and heal, 2 years so far health as before.
Beijing is in XX, and the women is diagnosed as the breast carcinoma initial stage, clothes Ruankang good for breast 26 days and heal, and 9 years so far are normal, do not have to occur unusually.
XX is opened in Beijing, the women, and enlargement of breast caking such as egg are big, clothes Ruankang good for breast seven days and healing.
The white XX in Beijing, the women suffers from breast cancer the initial stage, clothes Ruankang good for breast 24 days and healing.So far 3 years health as before.
Claims (1)
1. a medicine for the treatment of mastitis, mammary gland tumor, cyclomastopathy, breast carcinoma is characterized in that; Radix Angelicae Dahuricae 3-10g, Olibanum 3-10g, Myrrha 6-15g, Moschus 0.2-3g, Herba Taraxaci 10-18g, Radix Angelicae Sinensis body 3-10g, Fructus Forsythiae 6-15g, Radix Glycyrrhizae Preparata 3-10g, Flos Lonicerae 20-35g form, and pulverize superfine powder, and mix homogeneously is made powder or dressed up capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100311191A CN100427113C (en) | 2004-04-12 | 2004-04-12 | Ruankang good for breast |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100311191A CN100427113C (en) | 2004-04-12 | 2004-04-12 | Ruankang good for breast |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1682787A CN1682787A (en) | 2005-10-19 |
| CN100427113C true CN100427113C (en) | 2008-10-22 |
Family
ID=35262406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100311191A Expired - Fee Related CN100427113C (en) | 2004-04-12 | 2004-04-12 | Ruankang good for breast |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100427113C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552541B (en) * | 2012-01-16 | 2013-09-25 | 李伟丽 | Medicinal composition for preventing or treating breast cancer |
| CN102716431B (en) * | 2012-07-13 | 2013-12-04 | 宁夏大学 | Preparation method of traditional Chinese medicine plastic for treating bovine mastitis |
| CN104257911B (en) * | 2014-09-16 | 2018-07-06 | 韩旭 | Pharmaceutical composition and pharmaceutical preparation and its application |
| CN107569651A (en) * | 2017-09-13 | 2018-01-12 | 李晓艳 | A kind of emplastrum for treating proliferation of mammary gland mastitis |
| CN107929439A (en) * | 2018-01-01 | 2018-04-20 | 曹春利 | A kind of Chinese medicine for treating acute mastitis |
| CN109125430A (en) * | 2018-11-23 | 2019-01-04 | 张瑞武 | A kind of external medicine composition for cancer pain |
| CN116603026B (en) * | 2023-06-01 | 2024-07-23 | 叶青青 | Traditional Chinese medicine decoction for treating breast cancer by phyllanthus urinaria decoction |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1411836A (en) * | 2001-10-19 | 2003-04-23 | 郗继福 | Carthamus flower medicated liquor |
-
2004
- 2004-04-12 CN CNB2004100311191A patent/CN100427113C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1411836A (en) * | 2001-10-19 | 2003-04-23 | 郗继福 | Carthamus flower medicated liquor |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1682787A (en) | 2005-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101190310B (en) | Traditional Chinese medicine composition for treating mazopathy | |
| CN102688317B (en) | Traditional Chinese medicine for treating liver cancer | |
| CN100427113C (en) | Ruankang good for breast | |
| CN103099914B (en) | Traditional Chinese medicine composition for treating acute pancreatitis | |
| CN101810829B (en) | Medicament for treating mastopathy | |
| CN100374147C (en) | Traditional Chinese medicine preparation for treating mammary gland hyperplasia | |
| CN104027430B (en) | A kind of Chinese medicine composition for the treatment of blood stasis type hysteromyoma | |
| CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
| CN104491511A (en) | Traditional Chinese medicine external-applying preparation for treating hyperplasia of mammary glands | |
| CN105168259A (en) | Formulated traditional Chinese medicine composition for preventing and/or treating tumors, traditional Chinese medicine preparation and application | |
| CN105396019A (en) | Pharmaceutical composition for relieving radiotherapy reaction of tumor patients | |
| CN103656050A (en) | Traditional Chinese medicine ointment for treating mammary gland hyperplasia and preparation method thereof | |
| CN103893328A (en) | Traditional Chinese medicine pill used for treating hyperplasia of mammary glands | |
| CN101229297A (en) | A Chinese herbal tea preparation for treating internal and external mixed hemorrhoid | |
| CN105998983A (en) | Traditional Chinese medicinal composition for treating gynecological inflammation | |
| CN104800688A (en) | Traditional Chinese medicine composition for treating chronic nephritis and application | |
| CN105663832A (en) | Traditional Chinese medicine composition for treating radiodermatitis | |
| CN103816468B (en) | A kind of capsule treating gastric cancer and preparation method thereof | |
| CN105434764A (en) | Traditional Chinese medicine capsules for treating vitiligo | |
| CN103356957B (en) | Medicine for treating stomach cancer and preparation method thereof | |
| CN111481649A (en) | External traditional Chinese medicine composition for treating breast cancer and preparation method thereof | |
| CN102671032A (en) | Traditional Chinese medicine for treating recurrent aphthae | |
| CN106236952A (en) | A kind of Chinese medicine decoction for treating acne | |
| CN106138476A (en) | A kind of Chinese medicinal capsule for treating acne | |
| CN106038813A (en) | Medicine for treating pityriasis rosea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Sun Yuliang Document name: Notification of the application for patent for invention to go through the substantive examination procedure |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081022 Termination date: 20140412 |